AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/144
REJECTION TREATMENT AND RISK OF PNEUMOCYSTIS-CARINII PNEUMONIA AFTER RENAL-TRANSPLANT
Authors: AREND SM WESTENDORP RGJ VANTWOUT JW VANDERWOUDE FJ KROON FP VANES LA VANDENBROUCKE JP
Citation: Sm. Arend et al., REJECTION TREATMENT AND RISK OF PNEUMOCYSTIS-CARINII PNEUMONIA AFTER RENAL-TRANSPLANT, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1070-1070
HOW MUCH OF THE CARDIOPROTECTIVE EFFECT OF POSTMENOPAUSAL ESTROGENS IS REAL
Authors: VANDENBROUCKE JP
Citation: Jp. Vandenbroucke, HOW MUCH OF THE CARDIOPROTECTIVE EFFECT OF POSTMENOPAUSAL ESTROGENS IS REAL, Epidemiology, 6(3), 1995, pp. 207-208
A COMPARATIVE-STUDY OF ATYPICAL AND MELANOCYTIC NEVI ON THE TROPICAL ISLAND CURACAO AND IN THE NETHERLANDS
Authors: CRIJNS MB KLAVER CCW DEBOER A VANHEES CLM VERMEER BJ VANDENBROUCKE JP BERGMAN W
Citation: Mb. Crijns et al., A COMPARATIVE-STUDY OF ATYPICAL AND MELANOCYTIC NEVI ON THE TROPICAL ISLAND CURACAO AND IN THE NETHERLANDS, Melanoma research, 5(3), 1995, pp. 161-167
SURVIVAL IN FAMILIES WITH HEREDITARY PROTEIN-C DEFICIENCY, 1820 TO 1993
Authors: ALLAART CF ROSENDAAL FR NOTEBOOM WMP VANDENBROUCKE JP BRIET E
Citation: Cf. Allaart et al., SURVIVAL IN FAMILIES WITH HEREDITARY PROTEIN-C DEFICIENCY, 1820 TO 1993, BMJ. British medical journal, 311(7010), 1995, pp. 910-913
RESISTANCE TO ACTIVATED PROTEIN-C AND FACTOR-V LEIDEN AS RISK-FACTORSFOR VENOUS THROMBOSIS
Authors: BERTINA RM REITSMA PH ROSENDAAL FR VANDENBROUCKE JP
Citation: Rm. Bertina et al., RESISTANCE TO ACTIVATED PROTEIN-C AND FACTOR-V LEIDEN AS RISK-FACTORSFOR VENOUS THROMBOSIS, Thrombosis and haemostasis, 74(1), 1995, pp. 449-453
HYPERHOMOCYSTEINEMIA - A RISK FACTOR FOR PRIMARY DEEP-VEIN THROMBOSIS
Authors: DENHEIJER M KOSTER T BLOM HJ BOS GMJ BRIET E VANDENBROUCKE JP ROSENDAAL FR
Citation: M. Denheijer et al., HYPERHOMOCYSTEINEMIA - A RISK FACTOR FOR PRIMARY DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1110-1110
THE OPTIMAL INTENSITY OF ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES
Authors: CANNEGIETER SC ROSENDAAL FR WINTZEN AR VANDERMEER FJM VANDENBROUCKE JP BRIET E
Citation: Sc. Cannegieter et al., THE OPTIMAL INTENSITY OF ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES, Thrombosis and haemostasis, 73(6), 1995, pp. 1116-1116
LIFE EXPECTANCY IN PARENTS OF PATIENTS WITH ACTIVATED PROTEIN-C RESISTANCE
Authors: HILLE ETM KOSTER T ROSENDAAL FR VANDENBROUCKE JP
Citation: Etm. Hille et al., LIFE EXPECTANCY IN PARENTS OF PATIENTS WITH ACTIVATED PROTEIN-C RESISTANCE, Thrombosis and haemostasis, 73(6), 1995, pp. 1373-1373
RISK-FACTORS FOR THROMBOEMBOLISM AND BLEEDING IN THE ANTICOAGULANT TREATMENT OF PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES
Authors: CANNEGIETER SC ROSENDAAL FR WINTZEN AR VANDENBROUCKE JP BRIET E
Citation: Sc. Cannegieter et al., RISK-FACTORS FOR THROMBOEMBOLISM AND BLEEDING IN THE ANTICOAGULANT TREATMENT OF PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES, Thrombosis and haemostasis, 73(6), 1995, pp. 1402-1402
SERUM VALUES OF PEPSINOGENS AND ANTIBODIES TO HELICOBACTER-PYLORI IN RELATION TO A HISTORY OF PEPTIC-ULCER DISEASE AND NSAID USE
Authors: JANSSEN M DIJKMANS BAC VANDENBROUCKE JP BIEMOND I VANDUYN W ZWINDERMAN AH LAMERS CBHW
Citation: M. Janssen et al., SERUM VALUES OF PEPSINOGENS AND ANTIBODIES TO HELICOBACTER-PYLORI IN RELATION TO A HISTORY OF PEPTIC-ULCER DISEASE AND NSAID USE, Scandinavian journal of rheumatology, 24(4), 1995, pp. 204-208
A CENTURY OF MORTALITY IN 5 LARGE FAMILIES WITH POLYCYSTIC KIDNEY-DISEASE
Authors: FLORIJN KW NOTEBOOM MP VANSAASE JLCM CHANG PC BREUNING MH VANDENBROUCKE JP
Citation: Kw. Florijn et al., A CENTURY OF MORTALITY IN 5 LARGE FAMILIES WITH POLYCYSTIC KIDNEY-DISEASE, American journal of kidney diseases, 25(3), 1995, pp. 370-374
INPATIENT TREATMENT FOR ACTIVE RHEUMATOID-ARTHRITIS - CLINICAL COURSEAND PREDICTORS OF IMPROVEMENT
Authors: VLIELAND TPMV ZWINDERMAN AH VANDENBROUCKE JP BREEDVELD FC HAZES JMW
Citation: Tpmv. Vlieland et al., INPATIENT TREATMENT FOR ACTIVE RHEUMATOID-ARTHRITIS - CLINICAL COURSEAND PREDICTORS OF IMPROVEMENT, British journal of rheumatology, 34(9), 1995, pp. 847-853
ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN
Authors: BLOEMENKAMP KWM ROSENDAAL FR HELMERHORST FM BULLER HR VANDENBROUCKE JP
Citation: Kwm. Bloemenkamp et al., ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN, Lancet, 346(8990), 1995, pp. 1593-1596
ROLE OF CLOTTING FACTOR-VIII IN EFFECT OF VON-WILLEBRAND-FACTOR ON OCCURRENCE OF DEEP-VEIN THROMBOSIS
Authors: KOSTER T BLANN AD BRIET E VANDENBROUCKE JP ROSENDAAL FR
Citation: T. Koster et al., ROLE OF CLOTTING FACTOR-VIII IN EFFECT OF VON-WILLEBRAND-FACTOR ON OCCURRENCE OF DEEP-VEIN THROMBOSIS, Lancet, 345(8943), 1995, pp. 152-155
NSAID-ASSOCIATED UPPER GASTROINTESTINAL DAMAGE IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: DIJKMANS BAC JANSSEN M VANDENBROUCKE JP LAMERS CBHW
Citation: Bac. Dijkmans et al., NSAID-ASSOCIATED UPPER GASTROINTESTINAL DAMAGE IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Scandinavian journal of gastroenterology, 30, 1995, pp. 105-108
LOW INCIDENCE OF CHILDHOOD CELIAC-DISEASE IN THE NETHERLANDS
Authors: GEORGE EK MEARIN ML VANDERVELDE EA HOUWEN RHJ BOUQUET J GIJSBERS CFM VANDENBROUCKE JP
Citation: Ek. George et al., LOW INCIDENCE OF CHILDHOOD CELIAC-DISEASE IN THE NETHERLANDS, Pediatric research, 37(2), 1995, pp. 213-218
OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES
Authors: CANNEGIETER SC ROSENDAAL FR WINTZEN AR VANDERMEER FJM VANDENBROUCKE JP BRIET E
Citation: Sc. Cannegieter et al., OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES, The New England journal of medicine, 333(1), 1995, pp. 11-17
RELEASE OF TUMOR-NECROSIS-FACTOR - AN INNATE HOST CHARACTERISTIC THATMAY CONTRIBUTE TO THE OUTCOME OF MENINGOCOCCAL DISEASE
Authors: WESTENDORP RGJ LANGERMANS JAM DEBEL CE MEINDERS AE VANDENBROUCKE JP VANFURTH R VANDISSEL JT
Citation: Rgj. Westendorp et al., RELEASE OF TUMOR-NECROSIS-FACTOR - AN INNATE HOST CHARACTERISTIC THATMAY CONTRIBUTE TO THE OUTCOME OF MENINGOCOCCAL DISEASE, The Journal of infectious diseases, 171(4), 1995, pp. 1057-1060
SEROEPIDEMIOLOGY OF GASTRITIS IN JAPANESE AND DUTCH WORKING POPULATIONS - EVIDENCE FOR THE DEVELOPMENT OF ATROPHIC GASTRITIS THAT IS NOT RELATED TO HELICOBACTER-PYLORI
Authors: SCHLEMPER RJ VANDERWERF SDJ VANDENBROUCKE JP BIEMOND I LAMERS CBHW
Citation: Rj. Schlemper et al., SEROEPIDEMIOLOGY OF GASTRITIS IN JAPANESE AND DUTCH WORKING POPULATIONS - EVIDENCE FOR THE DEVELOPMENT OF ATROPHIC GASTRITIS THAT IS NOT RELATED TO HELICOBACTER-PYLORI, Gut, 37(2), 1995, pp. 199-204
SEROEPIDEMIOLOGY OF GASTRITIS IN JAPANESE AND DUTCH ULCER AND NONULCER MALE EMPLOYEES
Authors: SCHLEMPER RJ VANDERWERF SDJ VANDENBROUCKE JP BIEMONO I LAMERS CBHW
Citation: Rj. Schlemper et al., SEROEPIDEMIOLOGY OF GASTRITIS IN JAPANESE AND DUTCH ULCER AND NONULCER MALE EMPLOYEES, Gastroenterology, 108(4), 1995, pp. 213-213
LONG-TERM FOLLOW-UP IN A COHORT OF NEWLY-DIAGNOSED EPILEPTIC PATIENTS
Authors: SHACKLETON DP WESTENDORP RGJ TRENITE DGAK VANDENBROUCKE JP
Citation: Dp. Shackleton et al., LONG-TERM FOLLOW-UP IN A COHORT OF NEWLY-DIAGNOSED EPILEPTIC PATIENTS, Epilepsia, 36, 1995, pp. 222-222
HIGH-RISK OF THROMBOSIS IN PATIENTS HOMOZYGOUS FOR FACTOR-V LEIDEN (ACTIVATED PROTEIN-C RESISTANCE)
Authors: ROSENDAAL FR KOSTER T VANDENBROUCKE JP REITSMA PH
Citation: Fr. Rosendaal et al., HIGH-RISK OF THROMBOSIS IN PATIENTS HOMOZYGOUS FOR FACTOR-V LEIDEN (ACTIVATED PROTEIN-C RESISTANCE), Blood, 85(6), 1995, pp. 1504-1508
PROTEIN-C DEFICIENCY IN A CONTROLLED SERIES OF UNSELECTED OUTPATIENTS- AN INFREQUENT BUT CLEAR RISK FACTOR FOR VENOUS THROMBOSIS (LEIDEN THROMBOPHILIA STUDY)
Authors: KOSTER T ROSENDAAL FR BRIET E VANDERMEER FJM COLLY LP TRIENEKENS PH POORT SR REITSMA PH VANDENBROUCKE JP
Citation: T. Koster et al., PROTEIN-C DEFICIENCY IN A CONTROLLED SERIES OF UNSELECTED OUTPATIENTS- AN INFREQUENT BUT CLEAR RISK FACTOR FOR VENOUS THROMBOSIS (LEIDEN THROMBOPHILIA STUDY), Blood, 85(10), 1995, pp. 2756-2761
DISCONTINUING 2ND-LINE DRUGS IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) IN REMISSION - A 52-WEEK DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
Authors: WOLDE S BREEDVELD FC HERMANS J VANDENBROUCKE JP VANDELAAR MAFJ MARKUSSE HM JANSSEN M VANDENBRINK HR DIJKMANS BAC
Citation: S. Wolde et al., DISCONTINUING 2ND-LINE DRUGS IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) IN REMISSION - A 52-WEEK DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Arthritis and rheumatism, 38(9), 1995, pp. 207-207
A RANDOMIZED CLINICAL-TRIAL OF INPATIENT MULTIDISCIPLINARY TREATMENT VERSUS ROUTINE OUTPATIENT MANAGEMENT IN PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS (RA)
Authors: VLIET VTPM ZWINDERMAN AH VANDENBROUCKE JP BREEDVELD FC HAZES JMW
Citation: Vtpm. Vliet et al., A RANDOMIZED CLINICAL-TRIAL OF INPATIENT MULTIDISCIPLINARY TREATMENT VERSUS ROUTINE OUTPATIENT MANAGEMENT IN PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 38(9), 1995, pp. 536-536
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>